PDGFRB and pericardial effusion: It has been suggested that dasatinib provokes serositis (PE and/or pericardial effusion) by causing inhibition of PDGFR beta (PDGFRβ) or Src family kinases, leading to decrease in interstitial fluid pressure or increase endothelial permeability, respectively [3, 6], [7], [8].